Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children

Background. Modern therapy programs allow achieving high survival rates in children with acute lymphoblastic leukemia (ALL). However, there is a group of patients in whom a relapse occurs, which makes it necessary to search for optimal tools for monitoring remission and the earliest detection of ALL...

Full description

Bibliographic Details
Main Authors: Meri A. Shervashidze, Timur T. Valiev, Natalia A. Batmanova, Nikolai N. Tupitsyn, Irina N. Serebryakova
Format: Article
Language:Russian
Published: IP Habib O.N. 2020-05-01
Series:Современная онкология
Subjects:
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/34006/21716